Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Suspicious powder sent to western consulates in Istanbul - officials
Oscar de la Renta: The All-American fashion legend
Venezuela's Maduro slams Spain's Rajoy over jailed opponent
25 European banks set to fail health checks - sources
French court approves Kazakh tycoon Ablyazov's extradition to Russia
Brazil presidential campaign ends in slugfest over corruption
Mesmerising Northern Territory – its parks and indigenous culture
Henley in sole charge after birdie blitz at Sea Island
Dramas on fun way to teach English
Copyright © 1995-2014 Star Publications (M) Bhd (Co No 10894-D)